Scholarlink

<p>Long non-coding RNAs (lncRNAs) are pivotal regulators of cellular processes, but their specific functions in pulmonary epithelial homeostasis and idiopathic pulmonary fibrosis (IPF) pathogenesis are not fully defined. Building on our previous finding that SYISL modulates fibroblast behavior, we investigated its role in the epithelial compartment. We discovered that SYISL is significantly upregulated in alveolar epithelial cells from both IPF patients and bleomycin-induced fibrotic mice. Mechanistically, we identified desmoplakin (DSP) as a direct binding partner of SYISL. SYISL promotes DSP degradation, thereby relieving a key constraint on epithelial integrity. This event initiates a downstream signaling cascade, activating the PI3K–AKT pathway and promoting YAP1 dephosphorylation and nuclear translocation. Furthermore, we delineate how this axis reshapes the epigenetic landscape at the vimentin locus, enhancing H3K4me3 and H3K27ac marks to facilitate YAP1-driven transcription, which collectively promotes an EMT-associated state and increased epithelial plasticity. The resultant aberrant epithelial-mesenchymal crosstalk contributes to pathological extracellular matrix (ECM) deposition. Translating these insights into therapy, we show that intratracheal delivery of AAV-shSYISL prevents fibrosis, while SYISL-targeting antisense oligonucleotides (ASOs) can reverse established fibrotic lesions. In summary, our study defines a novel SYISL–DSP–Hippo/YAP regulatory axis that licenses pro-fibrotic epithelial plasticity and nominates SYISL as a promising therapeutic target for IPF.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

SYISL promotes pulmonary epithelial-mesenchymal transition and fibrosis through DSP–Hippo/YAP pathway

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月12日

查看全文
  • Cong Xia,
  • Sining Hou,
  • Xuqian Wang,
  • Wenyu Zhao,
  • Zhixia Wang,
  • Airu Chang,
  • Lianhui Cheng,
  • Huibing Liu,
  • Jiawei Wang,
  • Bin Li,
  • Xin Pan,
  • Shuang Huang,
  • Ying Cao,
  • Sakamoto Koji,
  • Zhongzheng Li,
  • Qiwen Wang,
  • Andrew Leask,
  • Lan Wang,
  • Guoying Yu

摘要

Long non-coding RNAs (lncRNAs) are pivotal regulators of cellular processes, but their specific functions in pulmonary epithelial homeostasis and idiopathic pulmonary fibrosis (IPF) pathogenesis are not fully defined. Building on our previous finding that SYISL modulates fibroblast behavior, we investigated its role in the epithelial compartment. We discovered that SYISL is significantly upregulated in alveolar epithelial cells from both IPF patients and bleomycin-induced fibrotic mice. Mechanistically, we identified desmoplakin (DSP) as a direct binding partner of SYISL. SYISL promotes DSP degradation, thereby relieving a key constraint on epithelial integrity. This event initiates a downstream signaling cascade, activating the PI3K–AKT pathway and promoting YAP1 dephosphorylation and nuclear translocation. Furthermore, we delineate how this axis reshapes the epigenetic landscape at the vimentin locus, enhancing H3K4me3 and H3K27ac marks to facilitate YAP1-driven transcription, which collectively promotes an EMT-associated state and increased epithelial plasticity. The resultant aberrant epithelial-mesenchymal crosstalk contributes to pathological extracellular matrix (ECM) deposition. Translating these insights into therapy, we show that intratracheal delivery of AAV-shSYISL prevents fibrosis, while SYISL-targeting antisense oligonucleotides (ASOs) can reverse established fibrotic lesions. In summary, our study defines a novel SYISL–DSP–Hippo/YAP regulatory axis that licenses pro-fibrotic epithelial plasticity and nominates SYISL as a promising therapeutic target for IPF.

Graphical abstract